OQS
INFI

Occudo Quantitative Strategies’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Occudo Quantitative Strategies’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,904
Closed -$9K – 1487
2022
Q2 		$9K Hold
13,904
– – ﹤0.01% 1100
2022
Q1 		$16K Hold
13,904
– – ﹤0.01% 1104
2021
Q4 		$31K Sell
13,904
-30,746
-69% -$77.2K ﹤0.01% 1026
2021
Q3 		$153K Buy
+44,650
New +$138K 0.02% 892

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Occudo Quantitative Strategies's INFI Position: Q3 2022 in Review

Occudo Quantitative Strategies sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 13,904 shares — an estimated $9K sold.

Occudo Quantitative Strategies first reported a position in INFI in Q3 2021 and held it in 4 quarters. The position peaked at $153K in Q3 2021. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • Occudo Quantitative Strategies reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,904 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $9K.
  • Occudo Quantitative Strategies first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Infinity Pharmaceuticals, Inc. position peaked at $153K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.